Adverse Events With Prednisone Plus Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Low Incidence of Corticosteroid-Associated Adverse Events on Long-Term Exposure to Low-Dose Prednisone Given With Abiraterone Acetate to Patients With Metastatic Castration-Resistant Prostate Cancer
Eur Urol 2016 Sep 01;70(3)438-444, K Fizazi, KN Chi, JS de Bono, LG Gomella, K Miller, DE Rathkopf, CJ Ryan, HI Scher, ND Shore, P De Porre, A Londhe, T McGowan, N Pelhivanov, R Charnas, MB Todd, B MontgomeryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.